Compounds, compositions and methods are provided for modulating the
expression of ACE2. The compositions comprise oligonucleotides, targeted
to nucleic acid encoding ACE2. Methods of using these compounds for
modulation of ACE2 expression and for diagnosis and treatment of diseases
and conditions associated with expression of ACE2 are provided.